Overview

"CHANGE COVID-19 Severity"

Status:
Recruiting

Trial end date:
2024-06-30

Target enrollment:

Participant gender:

Summary

We are conducting an investigator-initiated, single center, blinded, placebo-controlled, randomized clinical trial evaluating magnesium citrate combined with a probiotic for the treatment of adults hospitalized with COVID-19.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Vanderbilt University Medical Center

Treatments:

Magnesium citrate